Treatment of Psychotic Disorders

Efficacy and Safety of Antipsychotics

Quetiapine is noted to be safe and effective in open-label studies, according to the American Academy of Child and Adolescent Psychiatry 1
Clozapine has shown superior efficacy but has more serious side effects, including risk of neutropenia and seizures, in patients with treatment-resistant conditions, as recommended by the American Academy of Child and Adolescent Psychiatry 1
Administer the selected antipsychotic at a therapeutic dose for at least 4 weeks, as recommended by the American College of Psychiatry and The Lancet Psychiatry 2
The initial choice of antipsychotic should be made collaboratively with the patient based on side-effect and efficacy profiles, as recommended by The Lancet Psychiatry 2
Start with olanzapine at an initial dose of 7.5-10 mg/day for most patients, as recommended by the British Journal of Psychiatry 3

Consider clozapine after two failed adequate antipsychotic trials, in cases of treatment resistance, as recommended by the American College of Psychiatry, The Lancet Psychiatry, and the American Journal of Psychiatry 2, 4
If first treatment was risperidone, consider olanzapine (with metformin to manage weight gain), as recommended by The Lancet Psychiatry 2
If first treatment was olanzapine, consider switching to risperidone, according to The Lancet Psychiatry 2
For patients whose first-line treatment was a D2 partial agonist, consider amisulpride, risperidone, paliperidone, or olanzapine (with either samidorphan combination or concurrent metformin), as recommended by The Lancet Psychiatry 2
Use gradual cross-titration when switching medications, as advised by The Lancet Psychiatry 2

Antipsychotic medication should always be combined with psychosocial interventions, as recommended by the American Academy of Child and Adolescent Psychiatry 1
Include families in the assessment process and treatment plan, as recommended by the British Journal of Psychiatry 3
Provide psychoeducation to both patient and family about the nature of schizophrenia and its treatment, according to the British Journal of Psychiatry 3
Implement structured group programs tailored to the immediate needs of the patient, as advised by the British Journal of Psychiatry 3
The following evidence-based psychosocial interventions should be implemented concurrently with medication:

Monitor for extrapyramidal side effects, which should be avoided to encourage future adherence, as recommended by the British Journal of Psychiatry 3
Consider metformin with olanzapine to manage weight gain, as suggested by The Lancet Psychiatry 2
Regular monitoring for weight gain, diabetes, and dyslipidemia is necessary, as stated by Praxis Medical Insights 5

Treatment for common side effects:

Side Effect	Treatment
Acute dystonia	Anticholinergic medication
Parkinsonism	Lower antipsychotic dose, switch to another antipsychotic, or treat with anticholinergic medication
Akathisia	Lower antipsychotic dose, switch to another antipsychotic, add benzodiazepine, or add beta-blocker
Tardive dyskinesia	Treat with a VMAT2 inhibitor for moderate to severe cases, as recommended by the American Journal of Psychiatry [4]

Inadequate duration of antipsychotic trials (minimum 4 weeks needed) is a common pitfall, as stated by Praxis Medical Insights 5
Failure to monitor for and manage metabolic and neurological side effects is another common pitfall, according to Praxis Medical Insights 5
Premature discontinuation of medications after symptom resolution is also a common pitfall, as recommended by Praxis Medical Insights 5
Neglecting psychosocial interventions that improve long-term outcomes is a common pitfall, as stated by Praxis Medical Insights 5
Antipsychotic polypharmacy without adequate trials of monotherapy including clozapine is a common pitfall, according to Praxis Medical Insights 5
Failure to recognize and address treatment resistance promptly is another common pitfall, as recommended by Praxis Medical Insights 5